These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 18480846)

  • 1. Targeted delivery of a suicide gene to human colorectal tumors by a conditionally replicating vaccinia virus.
    Foloppe J; Kintz J; Futin N; Findeli A; Cordier P; Schlesinger Y; Hoffmann C; Tosch C; Balloul JM; Erbs P
    Gene Ther; 2008 Oct; 15(20):1361-71. PubMed ID: 18480846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic administration of a recombinant vaccinia virus expressing the cytosine deaminase gene and subsequent treatment with 5-fluorocytosine leads to tumor-specific gene expression and prolongation of survival in mice.
    Gnant MF; Puhlmann M; Alexander HR; Bartlett DL
    Cancer Res; 1999 Jul; 59(14):3396-403. PubMed ID: 10416601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo cancer gene therapy by adenovirus-mediated transfer of a bifunctional yeast cytosine deaminase/uracil phosphoribosyltransferase fusion gene.
    Erbs P; Regulier E; Kintz J; Leroy P; Poitevin Y; Exinger F; Jund R; Mehtali M
    Cancer Res; 2000 Jul; 60(14):3813-22. PubMed ID: 10919655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modified vaccinia virus Ankara as a vector for suicide gene therapy.
    Erbs P; Findeli A; Kintz J; Cordier P; Hoffmann C; Geist M; Balloul JM
    Cancer Gene Ther; 2008 Jan; 15(1):18-28. PubMed ID: 17992203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo preclinical low-field MRI monitoring of tumor growth following a suicide-gene therapy in an orthotopic mice model of human glioblastoma.
    Breton E; Goetz C; Kintz J; Accart N; Aubertin G; Grellier B; Erbs P; Rooke R; Constantinesco A; Choquet P
    C R Biol; 2010 Mar; 333(3):220-5. PubMed ID: 20338540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted chemotherapy for head and neck cancer with a chimeric oncolytic adenovirus coding for bifunctional suicide protein FCU1.
    Dias JD; Liikanen I; Guse K; Foloppe J; Sloniecka M; Diaconu I; Rantanen V; Eriksson M; Hakkarainen T; Lusky M; Erbs P; Escutenaire S; Kanerva A; Pesonen S; Cerullo V; Hemminki A
    Clin Cancer Res; 2010 May; 16(9):2540-9. PubMed ID: 20388844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The oncolytic effect of recombinant vesicular stomatitis virus is enhanced by expression of the fusion cytosine deaminase/uracil phosphoribosyltransferase suicide gene.
    Porosnicu M; Mian A; Barber GN
    Cancer Res; 2003 Dec; 63(23):8366-76. PubMed ID: 14678998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccinia as a vector for tumor-directed gene therapy: biodistribution of a thymidine kinase-deleted mutant.
    Puhlmann M; Brown CK; Gnant M; Huang J; Libutti SK; Alexander HR; Bartlett DL
    Cancer Gene Ther; 2000 Jan; 7(1):66-73. PubMed ID: 10678358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo gene therapy for colon cancer using adenovirus-mediated, transfer of the fusion gene cytosine deaminase and uracil phosphoribosyltransferase.
    Chung-Faye GA; Chen MJ; Green NK; Burton A; Anderson D; Mautner V; Searle PF; Kerr DJ
    Gene Ther; 2001 Oct; 8(20):1547-54. PubMed ID: 11704815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complex interactions between the replicating oncolytic effect and the enzyme/prodrug effect of vaccinia-mediated tumor regression.
    McCart JA; Puhlmann M; Lee J; Hu Y; Libutti SK; Alexander HR; Bartlett DL
    Gene Ther; 2000 Jul; 7(14):1217-23. PubMed ID: 10918490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new recombinant vaccinia with targeted deletion of three viral genes: its safety and efficacy as an oncolytic virus.
    Yang S; Guo ZS; O'Malley ME; Yin X; Zeh HJ; Bartlett DL
    Gene Ther; 2007 Apr; 14(8):638-47. PubMed ID: 17268533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined suicide gene therapy for human colon cancer cells using adenovirus-mediated transfer of escherichia coli cytosine deaminase gene and Escherichia coli uracil phosphoribosyltransferase gene with 5-fluorocytosine.
    Koyama F; Sawada H; Hirao T; Fujii H; Hamada H; Nakano H
    Cancer Gene Ther; 2000 Jul; 7(7):1015-22. PubMed ID: 10917204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytosine deaminase expressing human mesenchymal stem cells mediated tumour regression in melanoma bearing mice.
    Kucerova L; Matuskova M; Pastorakova A; Tyciakova S; Jakubikova J; Bohovic R; Altanerova V; Altaner C
    J Gene Med; 2008 Oct; 10(10):1071-82. PubMed ID: 18671316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic cancer therapy with a tumor-selective vaccinia virus mutant lacking thymidine kinase and vaccinia growth factor genes.
    McCart JA; Ward JM; Lee J; Hu Y; Alexander HR; Libutti SK; Moss B; Bartlett DL
    Cancer Res; 2001 Dec; 61(24):8751-7. PubMed ID: 11751395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fractionated radiation therapy in combination with adenoviral delivery of the cytosine deaminase gene and 5-fluorocytosine enhances cytotoxic and antitumor effects in human colorectal and cholangiocarcinoma models.
    Stackhouse MA; Pederson LC; Grizzle WE; Curiel DT; Gebert J; Haack K; Vickers SM; Mayo MS; Buchsbaum DJ
    Gene Ther; 2000 Jun; 7(12):1019-26. PubMed ID: 10871750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VSV-G pseudotyped, MuLV-based, semi-replication-competent retrovirus for cancer treatment.
    Qiao J; Moreno J; Sanchez-Perez L; Kottke T; Thompson J; Caruso M; Diaz RM; Vile R
    Gene Ther; 2006 Oct; 13(20):1457-70. PubMed ID: 16724095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-specific therapeutic effect induced by an oncolytic adenoviral vector containing heat shock protein 70 and prodrug activation genes.
    Liu Y; Ye T; Sun D; Maynard J; Deisseroth A
    Gene Ther; 2006 Aug; 13(16):1235-43. PubMed ID: 16617300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined suicide gene therapy for pancreatic peritoneal carcinomatosis using BGTC liposomes.
    Hajri A; Wack S; Lehn P; Vigneron JP; Lehn JM; Marescaux J; Aprahamian M
    Cancer Gene Ther; 2004 Jan; 11(1):16-27. PubMed ID: 14681723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suicide gene therapy with the yeast fusion gene cytosine deaminase/uracil phosphoribosyltransferase is not enough for pancreatic cancer.
    Fogar P; Navaglia F; Basso D; Greco E; Zambon CF; Fadi E; Falda A; Stranges A; Vannozzi F; Danesi R; Pedrazzoli S; Plebani M
    Pancreas; 2007 Oct; 35(3):224-31. PubMed ID: 17895842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of antitumor activity by gene amplification with a replicating but nondisseminating adenovirus.
    Bourbeau D; Lau CJ; Jaime J; Koty Z; Zehntner SP; Lavoie G; Mes-Masson AM; Nalbantoglu J; Massie B
    Cancer Res; 2007 Apr; 67(7):3387-95. PubMed ID: 17409449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.